Expanded Mutation Profiling in Appendix Peritoneal Metastasis has a Prognostic and Therapeutic Utility When Managed with Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy

被引：0
|
作者：
Zhang, C. [1 ]
Plambeck, B. [1 ]
Tu, A. [1 ]
Brown, K. [1 ]
Foster, J. M. [1 ]
机构：
[1] Univ Nebraska Med Ctr, Div Surg Oncol, Dept Surg, Omaha, NE USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2020年 / 27卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P248
引用
收藏
页码：S83 / S84
页数：2
相关论文
共 19 条
  • [1] Exploring the prognostic and therapeutic utility of expanded mutation profiling in appendix peritoneal metastasis managed with CRS/HIPEC
    Zhang, Chunmeng
    Plambeck, Benjamin D.
    Craig, Margaret E.
    Tu, Alexander
    Mikus, Ryan J.
    Shostrom, Valerie
    McDermott, Sean P.
    Igbinigie, Ikponmwosa
    Brown, Krista
    Cushman-Vokoun, Allison
    Foster, Jason M.
    JOURNAL OF SURGICAL ONCOLOGY, 2021, 123 (07) : 1599 - 1609
  • [2] Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy in the Management of Colorectal Peritoneal Metastasis
    Hall, Bradley
    Padussis, James
    Foster, Jason M.
    SURGICAL CLINICS OF NORTH AMERICA, 2017, 97 (03) : 671 - +
  • [3] Prognostic role of body composition in peritoneal carcinomatosis patients undergoing cytoreduction and hyperthermic intraperitoneal chemotherapy
    Young Song
    Myung Il Bae
    Dong Woo Han
    Eun Jung Park
    Sujung Park
    Sung Yeon Ham
    World Journal of Surgical Oncology, 21
  • [4] Combined Mucinous and Neuroendocrine Tumours of the Appendix Managed with Surgical Cytoreduction and Oxaliplatin-based Hyperthermic Intraperitoneal Chemotherapy
    Hajjar, Roy
    Dube, Pierre
    Mitchell, Andrew
    Sideris, Lucas
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (01)
  • [5] Prognostic role of body composition in peritoneal carcinomatosis patients undergoing cytoreduction and hyperthermic intraperitoneal chemotherapy
    Song, Young
    Bae, Myung Il
    Han, Dong Woo
    Park, Eun Jung
    Park, Sujung
    Ham, Sung Yeon
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2023, 21 (01)
  • [6] Prognostic Analysis of Clinical and Biological Factors in Patients with Peritoneal Mesothelioma Treated by Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy
    Deraco, M.
    Villa, R.
    Daidone, M. G.
    Baratti, D.
    Kusamura, S.
    Motta, R.
    Venturini, L.
    Zaffaroni, N.
    ANNALS OF SURGICAL ONCOLOGY, 2009, 16 : 85 - 85
  • [7] Inflammation-Based Prognostic Scores: Utility in Prognostication and Patient Selection for Cytoreduction and Perioperative Intraperitoneal Chemotherapy in Patients with Peritoneal Metastasis of Colonic Origin
    Chukwuemeka Ihemelandu
    Annals of Surgical Oncology, 2017, 24 : 884 - 889
  • [8] Inflammation-Based Prognostic Scores: Utility in Prognostication and Patient Selection for Cytoreduction and Perioperative Intraperitoneal Chemotherapy in Patients with Peritoneal Metastasis of Colonic Origin
    Ihemelandu, Chukwuemeka
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (04) : 884 - 889
  • [9] Liquid biopsy in peritoneal fluid and plasma as a prognostic factor in advanced colorectal and appendiceal tumors after complete cytoreduction and hyperthermic intraperitoneal chemotherapy
    Lopez-Rojo, Irene
    Olmedillas-Lopez, Susana
    Villarejo Campos, Pedro
    Dominguez Prieto, Victor
    Barambio Buendia, Javier
    Cortes Guiral, Delia
    Garcia-Arranz, Mariano
    Garcia-Olmo, Damian
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [10] Insight into Predictors of Cytoreduction Score Following Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemotherapy for Gastric Peritoneal Carcinomatosis Improves Patient Selection and Prognostic Outcomes
    Hamed, Ahmed B.
    El Asmar, Rudy
    Tirukkovalur, Nikhil
    Tcharni, Adam
    Tatsuoka, Curtis
    Jelinek, Mark
    Derby, Joshua
    Dubrovsky, Genia
    Nunns, Geoffrey
    Ongchin, Melanie
    Pingpank, James F.
    Zureikat, Amer H.
    Bartlett, David L.
    Singhi, Aatur
    Choudry, M. Haroon
    Almasri, Samer S.
    ANNALS OF SURGICAL ONCOLOGY, 2025, 32 (01) : 199 - 208
12